Vistagen Therapeutics (VTGN) Short Interest Ratio & Short Volume $3.68 +0.04 (+1.10%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Vistagen Therapeutics Short Interest DataCurrent Short Interest799,800 sharesPrevious Short Interest867,600 sharesChange Vs. Previous Month-7.81%Dollar Volume Sold Short$3.13 millionShort Interest Ratio6.1 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares27,060,000 sharesFloat Size24,310,000 sharesShort Percent of Float3.29%Today's Trading Volume64,082 sharesAverage Trading Volume97,651 sharesToday's Volume Vs. Average66% Short Selling Vistagen Therapeutics ? Sign up to receive the latest short interest report for Vistagen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTGN Short Interest Over TimeVTGN Days to Cover Over TimeVTGN Percentage of Float Shorted Over Time Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Vistagen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2024799,800 shares $3.13 million -7.8%3.3%6.1 $3.91 6/30/2024867,600 shares $3.02 million -2.5%3.6%6.1 $3.48 6/15/2024889,500 shares $3.13 million -11.1%3.7%4.6 $3.52 5/31/20241,000,000 shares $3.86 million -5.7%4.1%4.9 $3.86 5/15/20241,060,000 shares $4.87 million -10.2%4.4%4.6 $4.59 4/30/20241,180,000 shares $5.70 million -8.5%4.9%4.6 $4.83 Get the Latest News and Ratings for VTGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vistagen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/20241,290,000 shares $6.13 million +0.8%5.3%4.9 $4.75 3/31/20241,280,000 shares $6.76 million -3.8%5.3%4.4 $5.28 3/15/20241,330,000 shares $5.39 million -8.9%5.5%4.7 $4.05 2/29/20241,460,000 shares $7.46 million -15.1%6.0%3.6 $5.11 2/15/20241,720,000 shares $9.32 million +27.4%7.1%4.1 $5.42 1/31/20241,350,000 shares $6.45 million +16.4%5.6%2.6 $4.78 1/15/20241,160,000 shares $6.32 million -28.8%4.8%2.1 $5.45 12/31/20231,630,000 shares $8.38 million +37.0%6.7%2.7 $5.14 12/15/20231,190,000 shares $5.93 million -4.8%4.9%1.8 $4.98 11/30/20231,250,000 shares $4.49 million -21.4%5.1%2.1 $3.59 11/15/20231,590,000 shares $5.23 million +2.6%6.4%2.7 $3.29 10/31/20231,550,000 shares $4.93 million +14.8%7.0%1.4 $3.18 10/15/20231,350,000 shares $4.64 million +61.6%6.1%0.7 $3.44 9/30/2023835,300 shares $4.38 million +16.8%3.5%0.4 $5.24 9/15/2023715,100 shares $4.25 million -31.9%7.7%0.4 $5.95 8/31/20231,050,000 shares $5.60 million -18.0%11.3%0.6 $5.33 8/15/20231,280,000 shares $8.04 million +132.2%13.8%0.7 $6.28 7/31/2023551,300 shares $1.00 million +18.1%7.0%0.4 $1.82 7/15/2023467,000 shares $826,590.00 +36.3%6.0%2.3 $1.77 6/30/2023342,600 shares $640,662.00 -50.2%4.4%1.7 $1.87 6/15/2023687,500 shares $1.43 million +72.2%9.5%3.2 $2.08 5/31/2023399,200 shares $1.70 million -96.8%N/A2.3 $4.26 5/15/202312,450,000 shares $1.75 million -12.0%N/A3.6 $0.14 4/30/202314,150,000 shares $1.98 million -10.6%N/A3 $0.14 4/15/202315,820,000 shares $2.19 million +25.0%N/A2.9 $0.14 3/31/202312,660,000 shares $1.58 million +47.7%N/A2.1 $0.12 3/15/20238,570,000 shares $1.31 million +17.4%N/A1.2 $0.15 2/28/20237,300,000 shares $1.28 million -14.9%N/A1 $0.18 2/15/20238,580,000 shares $1.70 million -15.8%N/A1.1 $0.20 1/31/202310,190,000 shares $2.64 million -17.8%N/A1.5 $0.26 1/15/202312,400,000 shares $1.98 million -19.7%N/A2.1 $0.16 12/30/202215,440,000 shares $1.59 million +36.9%N/A2.5 $0.10 12/15/202211,280,000 shares $1.27 million +24.2%N/A2.1 $0.11 11/30/20229,080,000 shares $1.25 million -1.2%N/A1.7 $0.14Dave Ramsey Makes Big Mistake Live On Air (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE 11/15/20229,190,000 shares $1.46 million +13.7%N/A1.5 $0.16 10/31/20228,080,000 shares $1.07 million +26.5%4.6%0.9 $0.13 10/15/20226,390,000 shares $713,124.00 +12.9%3.6%0.5 $0.11 9/30/20225,660,000 shares $860,886.00 +18.4%3.2%0.4 $0.15 9/15/20224,780,000 shares $916,326.00 -12.8%2.7%0.3 $0.19 8/31/20225,480,000 shares $1.01 million -13.3%3.1%0.4 $0.18 8/15/20226,320,000 shares $995,400.00 -30.1%4.1%0.5 $0.16 7/31/20229,040,000 shares $1.29 million -46.1%5.8%1.1 $0.14 7/15/202216,770,000 shares $13.08 million +16.1%10.8%3 $0.78 6/30/202214,440,000 shares $12.71 million +2.1%9.3%11.8 $0.88 6/15/202214,150,000 shares $13.35 million +30.7%8.8%10.7 $0.94 5/31/202210,830,000 shares $12.45 million +1.2%6.8%7.3 $1.15 5/15/202210,700,000 shares $12.20 million +0.1%6.7%7.2 $1.14 4/30/202210,690,000 shares $13.58 million +6.2%6.7%6.9 $1.27 4/15/202210,070,000 shares $16.31 million -2.4%6.3%6.3 $1.62 3/31/202210,320,000 shares $12.80 million -10.7%6.4%6.8 $1.24 3/15/202211,560,000 shares $13.18 million -2.3%7.2%8.3 $1.14 2/28/202211,830,000 shares $16.56 million +1.7%7.5%9.8 $1.40 2/15/202211,630,000 shares $18.61 million -0.5%7.3%9.3 $1.60 1/31/202211,690,000 shares $19.05 million +2.4%7.6%8.9 $1.63 1/15/202211,420,000 shares $19.87 million +2.2%7.4%9 $1.74 12/31/202111,170,000 shares $21.78 million +1.6%N/A9.1 $1.95 12/15/202110,990,000 shares $20.44 million +3.0%7.2%9.1 $1.86 11/30/202110,670,000 shares $20.59 million +3.3%7.0%8.8 $1.93 11/15/202110,330,000 shares $22.21 million -7.1%6.8%9 $2.15 10/29/202111,120,000 shares $25.46 million -4.6%7.7%10.4 $2.29 10/15/202111,650,000 shares $27.84 million -3.6%8.0%11.3 $2.39 9/30/202112,080,000 shares $33.10 million +29.5%8.3%11.1 $2.74 9/15/20219,330,000 shares $27.24 million -6.5%6.4%5.2 $2.92 8/31/20219,980,000 shares $30.34 million -8.4%6.9%5.2 $3.04 8/13/202110,890,000 shares $30.17 million -5.7%7.7%5.1 $2.77 7/30/202111,550,000 shares $30.72 million -1.4%7.9%4.2 $2.66 7/15/202111,710,000 shares $33.14 million -5.1%6.9%4 $2.83 6/30/202112,340,000 shares $38.87 million +88.7%7.3%4.2 $3.15 6/15/20216,540,000 shares $18.12 million -3.0%3.9%2.9 $2.77 5/28/20216,740,000 shares $17.46 million +2.9%4.0%3.1 $2.59 5/14/20216,550,000 shares $13.95 million +3.8%N/A2.8 $2.13 4/30/20216,310,000 shares $15.21 million +2.8%N/A2.1 $2.41 4/15/20216,140,000 shares $12.89 million -1.4%N/A1.9 $2.10 3/31/20216,230,000 shares $13.33 million -32.5%N/A1.8 $2.14 3/15/20219,230,000 shares $21.69 million +8.5%N/A2.1 $2.35 2/26/20218,510,000 shares $18.81 million +62.1%N/A2 $2.21 2/12/20215,250,000 shares $10.40 million -2.6%N/A1.3 $1.98 1/29/20215,390,000 shares $11.16 million +0.4%N/A2.1 $2.07 1/15/20215,370,000 shares $12.46 million +54.3%N/A2.3 $2.32 12/31/20203,480,000 shares $6.16 million +48.7%8.3%1.9 $1.77 12/15/20202,340,000 shares $1.75 million -18.5%N/A1.7 $0.75 11/30/20202,870,000 shares $2.21 million +2.9%N/A4.4 $0.77 10/30/20202,900,000 shares $2.18 million -9.4%N/A2.8 $0.75 10/15/20203,200,000 shares $2.44 million +27.5%N/A1.8 $0.76Dave Ramsey Makes Big Mistake Live On Air (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE 9/30/20202,510,000 shares $1.75 million -17.7%N/A1.1 $0.70 9/15/20203,050,000 shares $1.99 million -9.0%N/A1.3 $0.65 8/31/20203,350,000 shares $2.35 million +3.1%N/A1.4 $0.70 8/14/20203,250,000 shares $2.46 million +2.9%N/A1.3 $0.76 7/31/20203,160,000 shares $2.94 million +97.5%N/A1.4 $0.93 7/15/20201,600,000 shares $863,200.00 -10.6%N/A1.1 $0.54 6/30/20201,790,000 shares $943,509.00 +45.5%N/A1.9 $0.53 6/15/20201,230,000 shares $661,002.00 -3.9%3.0%1.5 $0.54 5/29/20201,280,000 shares $565,248.00 -2.3%3.1%1.8 $0.44 5/15/20201,310,000 shares $481,949.00 +6.5%3.2%2.5 $0.37 4/30/20201,230,000 shares $529,269.00 -8.2%3.0%3.3 $0.43 4/15/20201,340,000 shares $644,406.00 -2.9%3.3%4.2 $0.48 3/31/20201,380,000 shares $607,200.00 -4.6%3.4%4.5 $0.44 3/13/20201,447,000 shares $665,620.00 +8.8%3.7%4.7 $0.46 2/28/20201,330,000 shares $465,500.00 -22.2%3.4%1.9 $0.35 2/14/20201,710,000 shares $940,500.00 -21.6%4.3%2.4 $0.55 1/31/20202,180,000 shares $1.31 million -17.4%5.6%2.6 $0.60 1/15/20202,640,000 shares $1.93 million -8.3%7.0%3.2 $0.73 12/31/20192,880,000 shares $2.30 million +15.2%7.6%3.4 $0.80 VTGN Short Interest - Frequently Asked Questions What is Vistagen Therapeutics' current short interest? Short interest is the volume of Vistagen Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 799,800 shares of VTGN short. 3.29% of Vistagen Therapeutics' shares are currently sold short. Learn More on Vistagen Therapeutics' current short interest. What is a good short interest ratio for Vistagen Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTGN shares currently have a short interest ratio of 6.0. Learn More on Vistagen Therapeutics's short interest ratio. What is a good short interest percentage for Vistagen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.29% of Vistagen Therapeutics' floating shares are currently sold short. Is Vistagen Therapeutics' short interest increasing or decreasing? Vistagen Therapeutics saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 799,800 shares, a decline of 7.8% from the previous total of 867,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vistagen Therapeutics' float size? Vistagen Therapeutics currently has issued a total of 27,060,000 shares. Some of Vistagen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vistagen Therapeutics currently has a public float of 24,310,000 shares. How does Vistagen Therapeutics' short interest compare to its competitors? 3.29% of Vistagen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Vistagen Therapeutics: Merrimack Pharmaceuticals, Inc. (5.70%), Organogenesis Holdings Inc. (12.49%), Precigen, Inc. (9.81%), uniQure (6.55%), UroGen Pharma Ltd. (25.03%), Xeris Biopharma Holdings, Inc. (7.70%), Vanda Pharmaceuticals Inc. (5.06%), AC Immune SA (1.67%), Inozyme Pharma, Inc. (10.23%), ALX Oncology Holdings Inc. (26.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Vistagen Therapeutics stock? Short selling VTGN is an investing strategy that aims to generate trading profit from Vistagen Therapeutics as its price is falling. VTGN shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vistagen Therapeutics? A short squeeze for Vistagen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTGN, which in turn drives the price of the stock up even further. How often is Vistagen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTGN, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Merrimack Pharmaceuticals Short Interest Organogenesis Short Interest Precigen Short Interest uniQure Short Interest UroGen Pharma Short Interest Xeris Biopharma Short Interest Vanda Pharmaceuticals Short Interest AC Immune Short Interest Inozyme Pharma Short Interest ALX Oncology Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTGN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vistagen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vistagen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.